ESSA Pharma Inc (EPIX)
6.65
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
6.78
+0.13
(+1.95%)
After-Hours: 20:00
ESSA Pharma Research and Development Expense (TTM): 23.05M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 23.05M |
| December 31, 2023 | 21.36M |
| September 30, 2023 | 21.32M |
| June 30, 2023 | 20.45M |
| March 31, 2023 | 20.57M |
| December 31, 2022 | 23.74M |
| September 30, 2022 | 24.42M |
| June 30, 2022 | 26.34M |
| March 31, 2022 | 26.17M |
| December 31, 2021 | 25.79M |
| September 30, 2021 | 24.26M |
| June 30, 2021 | 20.22M |
| March 31, 2021 | 16.69M |
| December 31, 2020 | 14.04M |
| September 30, 2020 | 12.15M |
| June 30, 2020 | 11.91M |
| March 31, 2020 | 11.16M |
| December 31, 2019 | 7.997M |
| September 30, 2019 | 6.696M |
| June 30, 2019 | 5.618M |
| Date | Value |
|---|---|
| March 31, 2019 | 4.655M |
| December 31, 2018 | 5.190M |
| September 30, 2018 | 4.873M |
| June 30, 2018 | 5.112M |
| March 31, 2018 | 7.045M |
| December 31, 2017 | 7.604M |
| September 30, 2017 | 5.726M |
| June 30, 2017 | 8.512M |
| March 31, 2017 | 8.955M |
| December 31, 2016 | 8.951M |
| September 30, 2016 | 13.06M |
| June 30, 2016 | 8.317M |
| March 31, 2016 | 7.544M |
| December 31, 2015 | 7.532M |
| September 30, 2015 | 4.976M |
| June 30, 2015 | 5.659M |
| March 31, 2015 | 3.681M |
| December 31, 2014 | 1.177M |
| September 30, 2014 | 0.6313M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
5.618M
Minimum
Jun 2019
26.34M
Maximum
Jun 2022
18.20M
Average
20.51M
Median
Research and Development Expense (TTM) Benchmarks
| Acasti Pharma Inc | 4.638M |
| Aurinia Pharmaceuticals Inc | 49.64M |
| Edesa Biotech Inc | 3.860M |
| Lexaria Bioscience Corp | 2.961M |
| Xenon Pharmaceuticals Inc | 172.25M |